AS
AMELIA SUERMANN
OTSUKA AMERICA PHARMACEUTICAL, INC. · Rockville, MD · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
2
2 agencies contacted
Activity
filings by quarter
Works on
Specific issues
Implementation of the Inflation Reduction Act. Issues related to Medicare Part D redesign's impact on low-income subsidy beneficiaries.
Issues relating to agitation in Alzheimer's disease, early detection of PTSD, mental health parity and coordinated care, mental health equity, PBM reform, issues related to rare nephrology, 340B reform, psychedelics treatments for PTSD and mental health, and BIOSECURE Act, and the Ensuring Pathways to Innovate Cures (EPIC) Act, HR 7174.
Provisions related to the Continuing Appropriations and Other Matters Act, 2025 (HR 9494)
Issues relating to agitation in Alzheimer's disease, early detection of PTSD, mental health parity and coordinated care, mental health equity, PBM reform, The New Eras of Preventing End-Stage Kidney Disease Act (HR 6790) and rare nephrology issues, 340B reform, Psychedelics treatments for PTSD and mental health, and BIOSECURE Act.